Sanofi logs six trial updates: new Nuvaxovid, frexalimab, colitis studies and Fabry data lockNov 13Weekly roundup, 10 itemsfexofenadinefrexalimabUpdated
AstraZeneca-linked ovarian cancer trial posts results; myeloma follow-up study status reconfirmedNov 13Weekly roundup, 10 itemsAstraZenecaAZD0120Updated
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
Lyell completes LYL273 manufacturing transfer, pushes back Phase 1/2 data timelineSep 10Clinical readoutLyell Immunopharma, Inc.
AstraZeneca posts Phase 3 LOGOS, KALOS asthma results; updates Soliris labelJul 2Weekly roundup, 5 itemsAstraZenecaAZD4045